EPIDERMOLYSIS BULLOSA

This adverse event was reported 310 times

EPIDERMOLYSIS BULLOSA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Tetracycline-class Antibacterial [EPC] 3 0.0004
1 Penem Antibacterial [EPC] 11 0.0003
2 Cannabinoid [EPC] 2 0.0002
3 Human Immunoglobulin G [EPC] 5 0.0002
4 Mood Stabilizer [EPC] 49 0.0002
5 alpha-Glucosidase Inhibitor [EPC] 1 0.0002
6 CD30-directed Immunoconjugate [EPC] 2 0.0002
7 Osmotic Diuretic [EPC] 1 0.0002
8 Bismuth [EPC] 1 0.0002
9 Anti-epileptic Agent [EPC] 36 0.0002
See all drug classes enriched for association with EPIDERMOLYSIS BULLOSA